FADS2 and acute myeloid leukemia: Similarly, imetelstat, a telomerase inhibitor, heightens lipid peroxidation in AML cells by increasing polyunsaturated lipid content via ACSL4 and fatty acid desaturase 2 (FADS2), and its efficacy is improved following anthracycline/Ara‐C pretreatment [72].